1 |
Simanenkov V, Maev I, Tkacheva O, Alekseenko S, Andreev D, Bakulina N, Bakulin I, Bordin D, Vlasov T, Vorobyeva N, Grinevich V, Gubonina I, Drobizhev M, Efremov N, Karateev A, Kotovskaya Y, Kravchuk I, Krivoborodov G, Kulchavenya E, Lila A, Maevskaya M, Nekrasova A, Poluektova E, Popkova T, Sablin O, Solovyeva O, Suvorov A, Tarasova G, Trukhan D, Fedotova A. Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians. Terapevticheskii arkhiv. [DOI: 10.26442/00403660.2022.08.201523] [Reference Citation Analysis]
|
2 |
Chen L, Zhao X, Wei S, Ma X, Liu H, Li J, Jing M, Wang M, Zhao Y. Mechanism of Paeoniflorin on ANIT-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology. Front Pharmacol 2021;12:737630. [PMID: 34526905 DOI: 10.3389/fphar.2021.737630] [Reference Citation Analysis]
|
3 |
Salas-silva S, López-ramirez J, Barrera-chimal J, Lazzarini-lechuga R, Simoni-nieves A, Souza V, Miranda-labra RU, Masso F, Roma MG, Gutiérrez-ruiz MC, Bucio-ortiz L, Gomez-quiroz LE. Hepatocyte growth factor reverses cholemic nephropathy associated with α-naphthylisothiocyanate-induced cholestasis in mice. Life Sciences 2022;295:120423. [DOI: 10.1016/j.lfs.2022.120423] [Reference Citation Analysis]
|